Evidence map›Paper›PMID 28467868›Full record

ReviewThe New England journal of medicine2017

Academic, Foundation, and Industry Collaboration in Finding New Therapies.

Bonnie W Ramsey, Gerald T Nepom, Sagar Lonial

Registry-linked trialAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The New England journal of medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03251872 (Olaparib for Pulmonary Arterial Hypertension), which is not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03251872 early_phase1terminatednot on this mapstarted 2018, after this paper: background citation

Olaparib for Pulmonary Arterial Hypertension: a Pilot Clinical Study

TypeinterventionalSponsorLaval UniversityRan2018 to 2019Enrolled6ConditionsPulmonary Arterial HypertensionArmsOlaparib
3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Trial
  2. Considerations for early life genetic therapies in cystic fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bonnie W RamseyFrom the Department Pediatrics, University of Washington School of Medicine (B.W.R.), the Center for Clinical and Translational Research, Seattle Children's Research Institute (B.W.R.), the Immune Tolerance Network (G.T.N.), and the Benaroya Research Institute (G.T.N.) - all in Seattle; and the Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University School of Medicine, Atlanta (S.L.).
Gerald T NepomFrom the Department Pediatrics, University of Washington School of Medicine (B.W.R.), the Center for Clinical and Translational Research, Seattle Children's Research Institute (B.W.R.), the Immune Tolerance Network (G.T.N.), and the Benaroya Research Institute (G.T.N.) - all in Seattle; and the Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University School of Medicine, Atlanta (S.L.).
Sagar LonialFrom the Department Pediatrics, University of Washington School of Medicine (B.W.R.), the Center for Clinical and Translational Research, Seattle Children's Research Institute (B.W.R.), the Immune Tolerance Network (G.T.N.), and the Benaroya Research Institute (G.T.N.) - all in Seattle; and the Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University School of Medicine, Atlanta (S.L.).

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, Lucas R Hoffman · 2010 to 2026
$21.4M
NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Academic Medical CentersCooperative BehaviorDrug IndustryFoundationsGovernment AgenciesCystic FibrosisDiabetes Mellitus, Type 1HumansMultiple MyelomaPublic-Private Sector Partnerships

Identifiers

PMID28467868
PMCPMC5912685

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.